A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer
- 1 July 2012
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 30 (4) , 421-427
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Systemic Therapy of Advanced Urothelial CancerCurrent Treatment Options in Oncology, 2009
- Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trialsUrology, 2006
- The Effect of Repeat Transurethral Resection on Recurrence and Progression Rates in Patients With T1 Tumors of the Bladder Who Received Intravesical Mitomycin: A Prospective, Randomized Clinical TrialJournal of Urology, 2006
- RESTAGING TRANSURETHRAL RESECTION OF HIGH RISK SUPERFICIAL BLADDER CANCER IMPROVES THE INITIAL RESPONSE TO BACILLUS CALMETTE-GUERIN THERAPYJournal of Urology, 2005
- Intravesical Bacillus Calmette-Guerin Versus Mitomycin C For Superficial Bladder Cancer: A Formal Meta-Analysis of Comparative Studies on Recurrence and ToxicityJournal of Urology, 2003
- Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical TrialsJournal of Urology, 2002
- Sequential instillation therapy with mitomycin C and Adriamycin for superficial bladder cancerCancer Chemotherapy and Pharmacology, 1992
- Intravesical cisplatin for superficial bladder tumorsCancer, 1982
- Single and sequential combination intravesical chemotherapy of murine bladder cancerUrology, 1982